Posted by Administrator on April 12th, 2006 — in Viagra Top News
NEW YORK - In a sign of how Pfizer Inc. hopes to boost the market for erectile dysfunction drugs, the maker of impotency pill Viagra plans to launch a second non-branded, educational ad campaign about the condition on Wednesday to complement one running since late last year.
The double-dose of education comes as Pfizer tries to […]
No Comments »
Posted by Administrator on April 12th, 2006 — in Viagra Top News
Dear Dr. Donohue: Will you please address the issue of Viagra causing blindness? How risky is it to use Viagra? Should a man (a friend) take it if he has very little vision in one eye? I am very concerned.
— T.Y.
http://www.drugonline.cc
A: When the announcement was made about Viagra causing vision loss, many men were very […]
No Comments »
Posted by Administrator on April 12th, 2006 — in Viagra Top News
Pfizer is worried. Not enough men think they have a problem in bed, so Pfizer plans on launching a second campaign to make them understand that they just don’t have what it takes.
The problem for Pfizer is Viagra’s sagging sales; the problem for men, according to Pfizer, is impotence. But many men just don’t seem […]
No Comments »
Posted by Administrator on April 12th, 2006 — in Viagra Top News
Japan - the second largest single-country pharmaceutical market in the world - represents a very large and relatively untapped erectile dysfunction (ED) therapeutic market. After providing an overview of the ED landscape in Japan, this report examines why promotional campaigns for the ED drugs available in Japan have failed to generate the level of sales […]
No Comments »
Posted by Administrator on April 12th, 2006 — in Viagra Top News
Several promising new treatments may prolong lives as well as improve the quality of life for people living with pulmonary arterial hypertension. Research showing benefits of these novel drug therapies for lethal lung disease will be discussed today at the 26th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation […]
No Comments »
Posted by Administrator on April 12th, 2006 — in Viagra Top News
Interpretation:
We have interpreted this question to mean the use of viagra in treating erectile dysfunction.
Answer:
There are numerous secondary sources of evidence that discuss the evidence for Viagra in erectile dysfunction (ED). We will restrict our reply to two main pieces of research (if more are needed let us know).
http://www.drugonline.cc
Clinical Evidence has a chapter on […]
No Comments »
Posted by Administrator on April 12th, 2006 — in Viagra Top News
In January, under threat of further FDA regulation, the pharmaceutical industry adopted restrictive guidelines for direct-to-consumer drug advertisements. AP reports that the FDA’s habit of pulling ad campaigns (as with Viagra) has convinced drug companies that it’s smarter to sell a disease than its cure:
http://www.drugonline.cc
Total spending on drug advertising rose 4.9 percent to $4.7 billion […]
No Comments »
Posted by Administrator on April 5th, 2006 — in Viagra Top News
As part of a pilot project to help protect patients against counterfeit drugs, U.K. drugs giant GlaxoSmithKline (GSK) has begun placing security tags on all bottles of its HIV medicine, Trizivir, distributed in the United States. The bottles will be tagged with radio-frequency identification (RFID) technology, which will help to check if the bottle contains […]
No Comments »
Posted by Administrator on April 5th, 2006 — in Viagra Top News
The recognition of Viagra® brand is so good that almost every adult in knows, or at least has heard of the drug and can tell you how it works.
How does it work? It’s simple — when it works as intended, Viagra® causes that a man who is sexually stimulated gets an erection.
How does Viagra® cause […]
No Comments »
Posted by Administrator on April 5th, 2006 — in Viagra Top News
After a brief hiatus, Imprint sex columnist Russel Cole brings us his oh-so-incisive insight into impotence.
Readers thinking he may be the one to broach a tricky subject, especially amongst university-age guys who should be the paragons of virility, will be disappointed as the column degenerates rapidly into mundane anecdote about “standing in line at the […]
2 Comments »